FMC (FMC) News Today

FMC Corporation (NYSE: FMC) saw its shares fluctuate as investors weighed strong second‐quarter results and new product registrations against a wave of analyst price‐target cuts and downgrades.

• Positive Sentiment: FMC reported Q2 revenue and EPS above Wall Street estimates, driven by higher volumes that offset pricing pressures. FMC's Earnings Surpass Estimates in Q2
• Positive Sentiment: TipRanks highlighted FMC’s “strong Q2 2025 results,” underscoring management’s ability to navigate pricing challenges and maintain growth momentum. FMC Corporation Reports Strong Q2 2025 Results
• Positive Sentiment: FMC received registration in Great Britain for its Fundatis® herbicide powered by the novel Isoflex® active, expanding its product lineup in cereal crops. FMC Corporation obtains registration in Great Britain
• Positive Sentiment: KeyBanc raised its price target on FMC from $53 to $61 and maintained an “Overweight” rating, reflecting confidence in the company’s growth outlook. KeyBanc Raises PT on FMC Corporation
• Neutral Sentiment: Analysts at RBC, Morgan Stanley and UBS maintained “Sector Perform”/“Equal Weight”/“Neutral” ratings but trimmed price targets to the low $40s, signaling mixed near‐term expectations. Benzinga Summary of Analyst Price Target Changes
• Neutral Sentiment: FMC updated its FY 2025 EPS guidance to $3.26–$3.70 and Q3 EPS guidance to $0.78–$0.98, broadly in line with consensus estimates. FMC Updates FY 2025 and Q3 2025 Guidance
• Neutral Sentiment: MarketBeat reports a consensus “Hold” rating on FMC from 14 analysts, reflecting a balanced mix of sell, hold and buy opinions. FMC Receives Average Recommendation of Hold
• Negative Sentiment: Shares dropped following an 8.4% decline after an analyst downgrade, compounded by price‐target cuts from UBS (to $44), RBC (to $42) and Morgan Stanley (to $42). FMC Stock Price Down After Analyst Downgrade